Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Yen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34<sup>+</sup> cell therapy to induce fetal hemoglobin for sickle cell diseaseVarun Katta, Kiera O'Keefe, Yichao Li, et al.
Nature Communications|March 2, 2025
FLT1 and other candidate fetal haemoglobin modifying loci in sickle cell disease in African ancestriesAmbroise Wonkam, Kevin Esoh, Rachel M Levine, et al.
Blood Advances|August 27, 2025
A mouse model for hemoglobin SC disease recapitulates characteristic human pathologiesJinbin Zhai, James B Papizan, Yu Yao, et al.
Nature Genetics|July 3, 2023
Potent and uniform fetal hemoglobin induction via base editingThiyagaraj Mayuranathan, Gregory A Newby, Ruopeng Feng, et al.
Nature|June 3, 2021
Base editing of haematopoietic stem cells rescues sickle cell disease in miceGregory A Newby, Jonathan S Yen, Kaitly J Woodard, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 1, 2024
Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34<sup>+</sup> cell therapy to induce fetal hemoglobin for sickle cell diseaseVarun Katta, Kiera O'Keefe, Yichao Li, et al.
Nature Communications|March 2, 2025
FLT1 and other candidate fetal haemoglobin modifying loci in sickle cell disease in African ancestriesAmbroise Wonkam, Kevin Esoh, Rachel M Levine, et al.
Blood Advances|August 27, 2025
A mouse model for hemoglobin SC disease recapitulates characteristic human pathologiesJinbin Zhai, James B Papizan, Yu Yao, et al.
Nature Genetics|July 3, 2023
Potent and uniform fetal hemoglobin induction via base editingThiyagaraj Mayuranathan, Gregory A Newby, Ruopeng Feng, et al.
Nature|June 3, 2021
Base editing of haematopoietic stem cells rescues sickle cell disease in miceGregory A Newby, Jonathan S Yen, Kaitly J Woodard, et al.
Pageof 2